Related Experiment Videos

[Successful treatment of brain stem and thalamic abscesses with high-dose meropenem]

Toshihide Tanaka1, Hiroki Sakamoto, Naoki Kato

  • 1Department of Neurosurgery, Jikei University School of Medicine Kashiwa Hospital, Chiba, Japan.

Insights

High-dose meropenem effectively treated brain abscesses in two adult patients, leading to complete resolution and improved neurological function. This therapy is a viable option for abscesses in difficult-to-access brain regions.

Area of Science:

  • Neurology
  • Infectious Diseases
  • Pharmacology

Background:

  • Brain abscess incidence remains significant despite advances in antibiotic therapy.
  • Standard treatments for brain abscess include vancomycin or carbapenems.
  • High-dose meropenem's efficacy for brain abscess is occasionally reported.

Observation:

  • Two adult patients presented with neurological deficits suggestive of brain abscess.
  • MRI revealed ring-enhancing cystic lesions in the brainstem and basal ganglia.
  • Both patients received continuous high-dose meropenem (6g/day) intravenously for two months.

Findings:

  • Complete resolution of brain abscesses was achieved in both cases.
  • Neurological deficits associated with the abscesses significantly improved.
  • High-dose meropenem demonstrated effectiveness in treating brain abscesses.

Implications:

  • High-dose meropenem should be considered a potential treatment for brain abscess.
  • This therapy is particularly relevant for abscesses in surgically challenging locations like the brainstem and basal ganglia.
  • Meropenem offers a promising therapeutic strategy for complex brain abscess cases.

Related Concept Videos

Brain Abscess l: Introduction01:26

Brain Abscess l: Introduction

A brain abscess is a focal, intracerebral infection characterized by a localized collection of pus within the brain parenchyma, resulting from microbial invasion and the body’s inflammatory response. It progresses through stages: early and late cerebritis, followed by early and late capsule formation, reflecting tissue destruction, immune response, and eventual encapsulation.Etiology and PathogenesisCausative organisms vary with source and host factors, often involving polymicrobial infections,...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...